|
|
| HUMAN GENOME SCIENCES INVITES INVESTORS TO LISTEN TO WEBCAST OF PRESENTATION AT CIBC WORLD MARKETS INVESTMENT CONFERENCE | |
|
ROCKVILLE, Maryland – November 8, 2004 – Human Genome Sciences, Inc. (Nasdaq: HGSI) announced today that a member of the Company’s senior management team plans to participate in the 15 th Annual Healthcare Conference sponsored by CIBC World Markets on November 10, 2004. David C. Stump, M.D., Executive Vice President, Drug Development, will participate in a panel discussion beginning at 12:10 pm Eastern Time and will provide an overview of the Company beginning at 2:30 pm Eastern Time. Both webcasts may be accessed at www.hgsi.com. Investors interested in listening to the live webcasts should log on before the start times in order to download any software required. The archive of the webcasts will be available for several days after the live events. Human Genome Sciences is a company with the mission to treat and cure disease by bringing new gene-based drugs to patients. HGS and Human Genome Sciences are registered trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company’s web site at www.hgsi.com.
CONTACT: |